(Q42906278)

10 November 2017

Amelioration of cisplatin nephrotoxicity by genetic or pharmacologic blockade of prostaglandin synthesis (English)

1 reference

10 November 2017

1 reference

1 reference

Zhanjun Jia

1

1 reference

10 November 2017

Ningning Wang

2

1 reference

10 November 2017

Toshinori Aoyagi

3

1 reference

10 November 2017

Haiping Wang

4

1 reference

10 November 2017

Haiying Liu

5

1 reference

10 November 2017

Tianxin Yang

6

1 reference

10 November 2017

language of work or name

English

0 references

publication date

15 September 2010

1 reference

10 November 2017

1 reference

10 November 2017

79

1 reference

10 November 2017

1

1 reference

10 November 2017

77-88

1 reference

https://scigraph.springernature.com/pub.10.1038/ki.2010.331

10 November 2017

0 references

cites work

Cellular processing of platinum anticancer drugs

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.331

7 January 2021

Cisplatin: from DNA damage to cancer chemotherapy.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.331

7 January 2021

Cisplatin nephrotoxicity

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.331

7 January 2021

Cisplatin nephrotoxicity: mechanisms and renoprotective strategies

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.331

7 January 2021

G protein-coupled prostanoid receptors and the kidney

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.331

7 January 2021

Prostaglandin endoperoxide H synthases (cyclooxygenases)-1 and -2

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.331

7 January 2021

Prostaglandin E synthase: a novel drug target for inflammation and cancer

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.331

7 January 2021

Impaired inflammatory and pain responses in mice lacking an inducible prostaglandin E synthase

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.331

7 January 2021

Lipopolysaccharide-dependent prostaglandin E(2) production is regulated by the glutathione-dependent prostaglandin E(2) synthase gene induced by the Toll-like receptor 4/MyD88/NF-IL6 pathway

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.331

7 January 2021

Deletion of microsomal prostaglandin E2 (PGE2) synthase-1 reduces inducible and basal PGE2 production and alters the gastric prostanoid profile

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.331

7 January 2021

Cellular prostaglandin E2 production by membrane-bound prostaglandin E synthase-2 via both cyclooxygenases-1 and -2.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.331

7 January 2021

Regulation of prostaglandin E2 biosynthesis by inducible membrane-associated prostaglandin E2 synthase that acts in concert with cyclooxygenase-2

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.331

7 January 2021

Reduced pain hypersensitivity and inflammation in mice lacking microsomal prostaglandin e synthase-1.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.331

7 January 2021

Membrane prostaglandin E synthase-1: a novel therapeutic target

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.331

7 January 2021

TNF-alpha mediates chemokine and cytokine expression and renal injury in cisplatin nephrotoxicity

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.331

7 January 2021

Cisplatin-induced apoptosis in p53-deficient renal cells via the intrinsic mitochondrial pathway

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.331

7 January 2021

Deletion of microsomal prostaglandin E synthase-1 increases sensitivity to salt loading and angiotensin II infusion

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.331

7 January 2021

Deletion of microsomal prostaglandin E synthase-1 augments prostacyclin and retards atherogenesis.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.331

7 January 2021

Role of microsomal prostaglandin E synthase 1 in the kidney.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.331

7 January 2021

mPGES-1 deletion impairs diuretic response to acute water loading

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.331

7 January 2021

Microsomal prostaglandin synthase-1-derived prostaglandin E2 protects against angiotensin II-induced hypertension via inhibition of oxidative stress

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.331

7 January 2021

Immunolocalization of a microsomal prostaglandin E synthase in rabbit kidney

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.331

7 January 2021

Microsomal prostaglandin E synthase-1 and blood pressure regulation

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.331

7 January 2021

Interleukin-10 inhibits ischemic and cisplatin-induced acute renal injury

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.331

7 January 2021

Protection against cisplatin-induced toxicities by N-acetylcysteine and sodium thiosulfate as assessed at the molecular, cellular, and in vivo levels

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.331

7 January 2021

The role of oxygen free radicals in cisplatin-induced acute renal failure in rats.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.331

7 January 2021

Antioxidant ameliorates cisplatin-induced renal tubular cell death through inhibition of death receptor-mediated pathways

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.331

7 January 2021

The protective effect of melatonin on cisplatin nephrotoxicity

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.331

7 January 2021

Selenium and high dose vitamin E administration protects cisplatin-induced oxidative damage to renal, liver and lens tissues in rats.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.331

7 January 2021

Effects of hydroxyl radical scavenging on cisplatin-induced p53 activation, tubular cell apoptosis and nephrotoxicity

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.331

7 January 2021

Protective effects of apocynin against cisplatin-induced oxidative stress and nephrotoxicity

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.331

7 January 2021

Cannabidiol attenuates cisplatin-induced nephrotoxicity by decreasing oxidative/nitrosative stress, inflammation, and cell death

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.331

7 January 2021

Differential upregulation of Nox homologues of NADPH oxidase by tumor necrosis factor-alpha in human aortic smooth muscle and embryonic kidney cells

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.331

7 January 2021

p38 MAP kinase inhibition ameliorates cisplatin nephrotoxicity in mice.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.331

7 January 2021

Salicylate reduces cisplatin nephrotoxicity by inhibition of tumor necrosis factor-alpha.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.331

7 January 2021

Cisplatin-induced nephrotoxicity is mediated by tumor necrosis factor-alpha produced by renal parenchymal cells

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.331

7 January 2021

Renal ischemia-reperfusion leads to long term infiltration of activated and effector-memory T lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.331

7 January 2021

Renal protection from ischemia mediated by A2A adenosine receptors on bone marrow-derived cells

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.331

7 January 2021

Platelet, but not endothelial, P-selectin is critical for neutrophil-mediated acute postischemic renal failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.331

7 January 2021

The role of ICAM-1 in endotoxin-induced acute renal failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.331

7 January 2021

Endotoxin and cisplatin synergistically induce renal dysfunction and cytokine production in mice

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.331

7 January 2021

Cisplatin effects on F-actin and matrix proteins precede renal tubular cell detachment and apoptosis in vitro

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.331

7 January 2021

Role of cyclooxygenase-2 in the control of renal haemodynamics and excretory function

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.331

7 January 2021

COX-2 inhibitor induced anuric renal failure in a previously healthy young woman

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.331

7 January 2021

The role of cycloxygenase-2 in the rodent kidney following ischaemia/reperfusion injury in vivo

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.331

7 January 2021

Cyclooxygenase 1 and/or 2 blockade ameliorates the renal tissue damage triggered by ischemia and reperfusion injury

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.331

7 January 2021

Effects of cyclooxygenase inhibitor treatment on the renal toxicity of cisplatin in rats.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.331

7 January 2021

Interaction of nimesulide, a cyclooxygenase-2 inhibitor, with cisplatin in normotensive and spontaneously hypertensive rats

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.331

7 January 2021

Expression and function of COX isoforms in renal medulla: evidence for regulation of salt sensitivity and blood pressure

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.331

7 January 2021

Inhibition of cyclooxygenase-2 in the rat renal medulla leads to sodium-sensitive hypertension

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.331

7 January 2021

Colorectal cancer and nonsteroidal anti-inflammatory drugs.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.331

7 January 2021

Hyperplastic gastric tumors induced by activated macrophages in COX-2/mPGES-1 transgenic mice

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.331

7 January 2021

Genetic deletion of mPGES-1 suppresses intestinal tumorigenesis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.331

7 January 2021

CS-706, a novel cyclooxygenase-2 selective inhibitor, prolonged the survival of tumor-bearing mice when treated alone or in combination with anti-tumor chemotherapeutic agents

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.331

7 January 2021

Nitro-oleic acid protects the mouse kidney from ischemia and reperfusion injury

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.331

7 January 2021

Activation and involvement of p53 in cisplatin-induced nephrotoxicity

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.331

7 January 2021

Identifiers

DOI

10.1038/KI.2010.331

1 reference

10 November 2017

1 reference